Clinical trials
Completed Coronary Artery Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
139 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 13 |
| 2008 | 7 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 12 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 10 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 139 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 16 |
| AstraZeneca | 5 |
| ECRI bv | 4 |
| University of Roma La Sapienza | 4 |
| Boston Scientific Corporation | 3 |
| CID - Carbostent & Implantable Devices | 3 |
| Cordis US Corp. | 3 |
| Elixir Medical Corporation | 3 |
| IRCCS San Raffaele | 3 |
| University Hospital of Ferrara | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 139 |
| Myocardial Ischemia | 15 |
| Coronary Stenosis | 14 |
| Acute Coronary Syndrome | 10 |
| Coronary Disease | 10 |
| Coronary Restenosis | 10 |
| Atherosclerosis | 8 |
| Cardiovascular Diseases | 7 |
| Vascular Diseases | 7 |
| Angina, Stable | 6 |
Trials
Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.
39 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.